SEC Filing: Form 8-K
Current report
VYNE TherapeuticsRooted in Innovation
VYNE Therapeutics
Current report
General statement of acquisition of beneficial ownership – amendment
Current report
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities